Kodiak Sciences Announces Presentation of KSI-301 Phase 1b Clinical Study Data Focused on Diabetic Macular Edema at American Academy of Ophthalmology (AAO) 2020 Virtual Meeting
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq futures sink as AI doubts resurface, oil jumps
- Oil jumps on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- JPMorgan says AI stock selling may be nearing its limit as positioning resets
| (NASDAQ: KOD) | Delayed: 87.72 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $87.72 | 52 Week High | $ | |||
| Open | $87.72 | 52 Week Low | $ | |||
| Day High | $87.72 | P/E | N/A | |||
| Day Low | $87.72 | EPS | $ | |||
| Volume | 20,936 | |||||
